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We have mvesttgated the effect of glucose on the release of endothehn-l-hke tmmunoreacttvity (ET-I-LI) from cultured bowne aorttc endothehal 
cells. Elevatton of glucose concentrattons m cultured medta from 5.5 to I1 I or 22 2 mM stgntlicantly sttmulated ET-I-L1 release from cultured 
endothehal cells An aldose reductase tnhtbitor dtd not affect the high glucose-Induced ET-l-L1 release. These findmgs suggest the possibility that 
hyperglycemia m dtabettc pattents enhances ET-I-L1 release at the local sate of vascular endothehum. whtch mtght be Involved tn the developments 
of vascular comphcattons and atheroscleroats. 
Endothelm. Endothehal cell, Glucose. Diabetes melhtus 
1. INTRODUCTION 
Hyperglycemia is generally accepted as the major 
cause of vascular complications in diabetic patients. 
Toxic effects of excess glucose including the 
hyperosmotic action, nonenzymatic glycosylation of 
various proteins, or increase in an intracellular sorbitol 
concentration by activating aldose reductase have been 
thought to be responsible for alteration of the functions 
of vascular endothelial cells and the subsequent 
development of atherosclerosis, although the precise 
mechanism is still unknown. Endothelin (ET), which is 
a peptide hormone with 21 amino acid residues recently 
isolated from the culture medium of porcine aortic en- 
dothelial cells [l], exerts a wide spectrum of effects on 
vasculature such as a potent vasoconstriction [l] and 
mitogenesis [2,3], suggesting a possible involvement of 
ET in the pathogenesis of atherosclerosis. In the pre- 
sent study, to evaluate the possibility that moderately 
elevated levels of blood glucose seen commonly in 
diabetic patients can affect the metabolism of ET, we 
have examined the effects of the elevated concentra- 
tions of glucose on the secretion of ET-l-like im- 
munoreactivity (ET-I-LI) from cultured bovine aortic 
endothelial cells. 
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2. MATERIALS AND METHODS 
2.1 Cell culture 
Endothehal cells were scraped off from the tnttma of bovme 
thoracic aorta, subcultured and characterwed as described previously 
[4,5]. The cell, from 4th to 7th passage were harvested by trypsintra- 
tion (O.OZob, w/v) and further seeded Into Costar 6-well plates. 
About 12 h later, the medium tia\ remoced and cultured m Dulbec- 
co’s modtfted Eagle’s medtum (DMEhI) (Gibco Laboratortes, Grand 
Island, NY) rupplemented wtth 10% heat-Inactivated fetal calf serum 
(FCS) containing various concentrattons of glucose, mannitol and 
ICI 128436 (statil; ICI Pharm., Ilacclesfteld, UK) [6] usually for 7-8 
days until confluent. When the cells reached confluency (2.0 x 10’ 
cells/well). they v.ere washed t\\tce with phosphate-buffered saline 
(PBS; pH 7 1) and the medium was changed to FCS-free medium 
contammg vartous concentrattons of glucose, manmtol and stattl. 
The media were then collected for measurement of the concentratton 
of ET-l-I.1 at variou, ttme tnter\al>. 
2.2. Meuwrernent of ET-I-LI 
ET-l-L1 released into the media *as measured by direct radiotm- 
munoassay (RIA) as prewously described [7]. Briefly, synthetic ET-l 
(Pepttde Instttute. Osaka. Japan) and monoiodinated ET-l 
([“‘IlET-1, 2.10-2.15 ~CI. pmol) prepared as prevtously detcrtbed 
[8] here used as standard and tracer The antiserum raised agamst 
ET-l(Hisih-Trp’t), ‘.4s-N7’ [7] has used m the present study. The 
cross-reactivttiea of ET-I, ET-‘, ET-3 and human big ET-l were 100, 
100, 100 and O.OOlR. respecttvely, on a molar basis The mimmal 
detectable quantity and the 50% inhtbitton of binding uere 
2 fmol/tube and 20 fmol/‘tube. respecttvely, for ET-1 using the an- 
ttserum at a fmal dtlutton of 1 .250000 (Ftg. I) The intra- and mter- 
assay coeffictents of variance (n = 10) were 6 3% and 8.Oob. respec- 
timely. 
2.3. Reverse-phase HPLC 
The medta collected were lyophihred, reconstttuted with the in- 
ittatmg solvent and inJected onto an ODS-120T column (0.46 cm x 
25 cm. Toyo-Soda. Tokyo. Japan). A ltnear gradient of acetomtrde 
from 10% to 60% in O.Ol’% trifluoroacettc acid was apphed over a 
pertod of 60 min at a llow rate of I ml/ min. Fractions were collected 
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stat,, _ _ + Fig. 1. A standard curve of ET-l (0) with the antiserum ‘As-N?, 
the cross-reactivity of human big ET-l(l-38) (A), and the dilution 
curve of the conditioned medtum from cultured bovine aortrc 
endothehal cells (v). 
Fig. 3. Effects of glucose, mannitol and statil on ET-I-L1 release for 
24 h by cultured bovme aortic endothelial cells. Values are expressed 
as means k SE of 4 different experiments. Comparisons were done 
by a Newman-Keuls test. * P < 0.01. 
every 36 s and sublected to RIA for ET-l. The recovery of ET-l-L1 
during the chromatography was more than 90%. 
2.4. Other analytical procedures 
Sorbitol levels were determined by a fluorescent enzymatic assay 
according to the method of Malone et al. [9]. Endothelial cells in 
Costar 6-well plates were washed twice and scraped off. The cells col- 
fected in 1 ml of PBS, were sonicated for 1 min and centrifuged at 
12000 x g for 30 min. After centrifugation, the resulting supernatant 
was subjected to the measurement of sorbitol. Single and multiple 
comparisons were performed by a Student’s t-test, and by analysis of 
variance followed by a ~e~rnan-Keuls test, respectively. 
3. RESULTS 
When confluent bovine aortic endothelial cells were 
incubated with KS-free DMEM over a 24 h period, 
the content of ET-l-L1 in the culture media increased 
linearly with time, and the release of ET-I-L1 from the 
cultured cells was significantly enhanced by elevating 
the concentration of glucose in DMEM from 5.5 to 
22.2 mM (Fig. 2). The dilution curve of the culture 
media was parallel to that of standard ET-l (Fig. 1). 
The elevation of glucose level from 5.5 to 11.1 mM aIso 
significantly increased the ET-l-L1 release (3.7 * 0.2 vs 
5.0 f 0.4 ng/105 cells/24 h, mean t- SE, n = 4, P < 
O.Ol), but simpie elevation of osmotic pressure by in- 
clusion of 16.7 mM mannitol in the media containing 
5.5 mM glucose did not affect the ET-l-L1 release 
(3.7 + 0.2 vs 3.9 rt 0.1 ng/lO’ cells/24 h; n = 4) 
(Fig. 3). The addition of an aldose reductase inhibitor 
of statil in the incubation media containing 22.2 mM 
glucose did not suppress the hyperglycemia-induced in- 
crease of ET-l-L1 release (5.4 I~I 0.3 vs 5.1 f 0.4 ng/lO’ 
cells/24 h; n = 4), although the hyperglycemia-induced 
increase of sorbitol content in the cells was corrected by 
the addition of the same concentration of statil 
(100 PM) (Table I). 
When the media obtained after incubation in the 
presence of 5.5 and 22.2 mM glucose were analyzed by 
reverse-phase HPLC followed by RIA for ET-I, it was 
shown that only an immunoreactive peak correspon- 
ding to authentic ET-l was increased by elevating 
glucose level, and that the contribution of big ET-1 to 
the ET-l immunoreactivities determined by the RIA 
present was negligible (Fig. 4). 
Table I 
Effects of elevated glucose levels and statn on mtracellular sorbitoi 
contents 
Conditions Sorbitol contents 
(nmol/me. nrotem) _____~ ~~ 
Control (glucose 5.5 mM) 10.6 i- 0 8 
Glucose 22.2 mM 14.9 + 0.7* 
Glucose 22.2 mM + stattl 12.2 + 0.7** 
Statil was added at a final concentration of IOOpM. Results are 
shown as means i SE of 4 experiments. * P < 0.01 vs control; ** P < 
0.05 vs 22.2 mM glucose; Student’s t-test 
-2 
Fig. 2. Time course of ET-l-L1 release by bovine aortic endothelial 
cells cuitured in DMEM containing 5.5 mM (0) and 22.2 mM (0) 
glucose. Values are expressed as means t SE of 3 experiments. * P < 
0.05, ** P < 0.001 vs 5.5 mM glucose; Student’s f-test. 
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Fig. 4. Reverse-phase HPLC analysis of cultured medta incubated 
with bovine endothelial cells m the presence of 5.5 mM (0) and 
22.2 mM (‘2) glucose. Arrows indicate the elution posmons of 
synthetic standards of (a) ET-3, (b) human big ET-l, (c) 
Met’-sulfoxide-ET-l, (d) ET-I, and (e) ET-2. 
4. DISCUSSION 111 
The epidemiologic studies have indicated that high 
blood glucose levels in diabetic patients are associated 
with increased risk of vascular complications [lo]. Our 
previous work demonstrated that a long-term exposure 
to high glucose is capable of altering the metabolism of 
endothelial cells [l I], and the present study clearly 
demonstrated that the elevation of glucose levels can 
stimulate ET-l-L1 release from cultured bovine aortic 
endothelial cells. Takahashi et al. [12] have recently 
reported that plasma-immunoreactive ET-l concentra- 
tions are greatly raised in the diabetic patients, which 
is compatible with our in vitro observations. Various 
chemical stimuli such as thrombin [I], epinephrine [I], 
calcium ionophore A23187 [I], phorbol esters [ 131, 
angiotensin II [14], vasopressin [14], and transforming 
growth factor-p (TGF-fl) [15] have been shown to aug- 
ment the secretion of ET-l. These agonists, except for 
TGF-8, stimulate ET-l release by activating protein 
kinase C (PKC). The mechanism of the stimulation of 
ET-l-L1 release by elevated concentrations of glucose is 
unknown. Our results indicated that neither the high 
osmotic pressure of the media nor the high concentra- 
tions of sorbitol in the cells enhanced the ET-l-L1 
release. Lee et al. [ 16,171 reported that the mem- 
branous pool of PKC activities in cultured bovine 
retinal capillary endothelial cells was increased after ex- 
posure to elevated glucose levels for 5 days, and the ad- 
dition of an aldose reductase inhibitor did not change 
PKC activity. The stimulating effect of glucose on ET-l 
secretion was observed after incubation with elevated 
levels of glucose for 5-6 days (data not shown). Those 
reported observations, together with the present fin- 
dings, might suggest that hyperglycemia-stimulated 
ET-l-L1 release is mediated by the activation of PKC 
activity. 
The present study, to our knowledge, is the first 
report demonstrating that the elevation of glucose 
levels to those usually encountered in diabetic patients 
can enhance the secretion of ET-l, and thus might pro- 
pose the possibility that endothelial damage and the 
subsequent acceleration of ET-l production by high 
blood glucose are involved in the developments of 
vascular complications and atherosclerosis by the 
mitogenic action of ET-l [2,3]. 
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